News

Santé log15h
Atea Pharmaceuticals Announces Continued Advancement of Global Phase 3 HCV Program with Dosing of First Patient in C-FORWARD Outside North America
About the Phase 3 C-BEYOND and C-FORWARD Trials in Adults with Chronic HCV ...
Pennsylvania Capital-Star1d
Bucks County nonprofits with unique missions brace for proposed funding cuts in biomedical research
Three Pennsylvania nonprofits share a uniquely focused mission on public health. Looming federal cuts to scientific research, ...
Gut5d
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
Background Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of the general population and is ...
MedPage Today on MSN5d
Warning for Hepatitis C Care; MASLD Deaths to Double; EHR Frustration for IBD Docs
Researchers warned of worsening health outcomes and financial strain for the 2 million Americans with hepatitis C if the Supreme Court cancels free preventive care covered by the Affordable Care Act.